Delphia (USA)’s Amgen AMGN Stock Holding History

Delphia (USA)’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,482	Closed	-$361K	–	291
2022 Q2	$361K	Sell	1,482 -5	-0.3%	-$1.23K	0.25%	140
2022 Q1	$360K	Buy	+1,487	New	+$342K	0.27%	137

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Delphia (USA)'s AMGN Position: Q3 2022 in Review

Delphia (USA) sold out of Amgen (AMGN) in Q3 2022, closing a stake of 1,482 shares — an estimated $361K sold.

Delphia (USA) first reported a position in AMGN in Q1 2022 and held it in 2 quarters. The position peaked at $361K in Q2 2022. 2,322 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.

Delphia (USA) reported no remaining Amgen position as of Q3 2022 after selling out during the quarter.
Delphia (USA) sold 1,482 Amgen shares in Q3 2022, an estimated $361K.
Delphia (USA) first reported a position in Amgen in Q1 2022 and held it in 2 quarters.
Delphia (USA)'s Amgen position peaked at $361K in Q2 2022.
2,322 funds tracked by Wall St. Rank held Amgen as of Q3 2022.

Based on Delphia (USA)'s 13F filing for Q3 2022, filed 14 Nov 2022.